Items where authors include "Bell, R"

Article

Partridge, JSL, Ryan, J, Dhesi, JK et al. (37 more authors) (2022) New guidelines for the perioperative care of people living with frailty undergoing elective and emergency surgery—a commentary. Age and Ageing, 51 (11). afac237. ISSN 0002-0729

Evans, RA, Leavy, OC, Richardson, M et al. (1003 more authors) (2022) Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. The Lancet Respiratory Medicine, 10 (8). pp. 761-775. ISSN 2213-2600

Woodhouse, A, Barnes, PM, Shorrock, A et al. (17 more authors) (2022) Trench floor depositional response to glacio-eustatic changes over the last 45 ka, northern Hikurangi subduction margin, New Zealand. New Zealand Journal of Geology and Geophysics. ISSN 0028-8306

Catto, JWF, Gordon, K orcid.org/0000-0003-1483-0657, Collinson, M orcid.org/0000-0003-3568-6455 et al. (15 more authors) (2021) Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study. Journal of Clinical Oncology, 39 (3). pp. 202-214. ISSN 0732-183X

Richardson, BH, Brown, C orcid.org/0000-0001-9697-4878, Heard, P et al. (13 more authors) (2020) The Advantage of Low and Medium Attractiveness for Facial Composite Production from Modern Forensic Systems. Journal of Applied Research in Memory and Cognition, 9 (3). pp. 381-395. ISSN 2211-3681

Coleman, RE, Collinson, M orcid.org/0000-0003-3568-6455, Gregory, W orcid.org/0000-0003-2641-8416 et al. (20 more authors) (2018) Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04). Journal of Bone Oncology, 13. pp. 123-135. ISSN 2212-1374

Wilson, C, Bell, R, Hinsley, S orcid.org/0000-0001-6903-4688 et al. (5 more authors) (2018) Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) study. European Journal of Cancer, 94. pp. 70-78. ISSN 0959-8049

Brown, J, Rathbone, E, Hinsley, S orcid.org/0000-0001-6903-4688 et al. (13 more authors) (2018) Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial. Journal of the National Cancer Institute, 110 (8). pp. 871-879. ISSN 0027-8874

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Alberro, JA, Ballester, B et al. (596 more authors) (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. The Lancet Oncology, 19 (1). pp. 27-39. ISSN 1470-2045

Coleman, R, Hall, A, Albanell, J et al. (10 more authors) (2017) Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial. The Lancet Oncology, 18 (11). pp. 1543-1552. ISSN 1470-2045

Wilson, C, Hinsley, S orcid.org/0000-0001-6903-4688, Marshall, H et al. (4 more authors) (2017) Reproductive hormone analyses and effects of adjuvant zoledronic acid in early breast cancer – an AZURE (BIG 01/04) sub-study. Journal of Bone Oncology, 9. pp. 48-54. ISSN 2212-1374

Bell, R, Brown, JM orcid.org/0000-0002-2719-7064, Parmar, M et al. (18 more authors) (2017) Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer. Annals of Oncology, 28 (4). pp. 754-760. ISSN 0923-7534

Gregory, WM, Twelves, CJ, Bell, R et al. (4 more authors) (2016) Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling. Breast Cancer Research and Treatment, 155 (2). pp. 303-311. ISSN 0167-6806

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Coleman, R, Powles, T et al. (102 more authors) (2015) Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet, 386 (10001). 1353 - 1361. ISSN 0140-6736

Tennant, PWG orcid.org/0000-0003-1555-069X, Bilous, RW, Prathapan, S et al. (1 more author) (2015) Risk and Recurrence of Serious Adverse Outcomes in the First and Second Pregnancies of Women With Preexisting Diabetes. Diabetes Care, 38 (4). pp. 610-619. ISSN 0149-5992

Coleman, R, Cameron, D, Dodwell, D et al. (13 more authors) (2014) Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. The Lancet Oncology, 15 (9). 997 - 1006. ISSN 1470-2045

Tennant, PWG, Glinianaia, SV, Bilous, RW et al. (2 more authors) (2014) Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: A population-based study. Diabetologia, 57 (2). pp. 285-294. ISSN 0012-186X

Coleman, R, Hinsley, S orcid.org/0000-0001-6903-4688, Bell, R et al. (7 more authors) (2013) Adjuvant therapy in early breast cancer with zoledronic acid (AZURE - BIG 01/04): Final efficacy analysis. European Journal of Cancer, 49 (Suppl 3). S5-S5. ISSN 0959-8049

Rathbone, EJ, Brown, JE, Marshall, HC et al. (11 more authors) (2013) Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04). Journal of Clinical Oncology, 31 (21). 2685 - 2691. ISSN 1527-7755

Coleman, RE, Marshall, H, Bell, R et al. (1 more author) (2012) Breast-cancer adjuvant therapy with zoledronic acid REPLY. New England Journal of Medicine, 366 (2). 189 - 189. ISSN 0028-4793

Kinnunen, TI, Tennant, PWG orcid.org/0000-0003-1555-069X, McParlin, C et al. (3 more authors) (2011) Agreement between pedometer and accelerometer in measuring physical activity in overweight and obese pregnant women. BMC Public Health, 11 (1). 501.

Coleman, R, Woodward, E, Brown, J et al. (11 more authors) (2011) Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer. Breast Cancer Research and Treatment, 127 (2). 429 - 438. ISSN 1573-7217

McParlin, C, Robson, SC, Tennant, PWG orcid.org/0000-0003-1555-069X et al. (5 more authors) (2010) Objectively measured physical activity during pregnancy: a study in obese and overweight women. BMC Pregnancy and Childbirth, 10 (1). 76.

Coleman, RE, Winter, MC, Cameron, D et al. (11 more authors) (2010) The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. British Journal of Cancer, 102 (7). 1099 - 1105. ISSN 0007-0920